Introduced
by
To establish that a drug manufacturer or distributor that gives a rebate or discount to a consumer is not guilty of bribery or kickbacks under the law that prohibits drug companies from bribing doctors or insurance companies to use their products.
Referred to the Committee on Health Policy
Reported without amendment
With the recommendation that the substitute (H-2) be adopted and that the bill then pass.
Substitute offered
To replace the previous version of the bill with one that revises details but does not change the substance of the bill as previously described.
The substitute passed by voice vote
Passed in the House 105 to 1 (details)
Referred to the Committee on Health Policy
Reported without amendment
With the recommendation that the bill pass.
Passed in the Senate 37 to 0 (details)
To establish that a medical supply or device manufacturer or distributor that gives a rebate or discount to a consumer is not guilty of bribery or kickbacks under the law that prohibits drug companies from bribing doctors or insurance companies to use their products.
